Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Glycoprotein – e.g. – mucins – proteoglycans – etc.
Reexamination Certificate
2002-05-03
2008-09-09
Kemmerer, Elizabeth C. (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Glycoprotein, e.g., mucins, proteoglycans, etc.
C435S006120, C435S007200, C435S069100, C435S069700, C435S069800, C530S350000, C536S023400, C536S023500
Reexamination Certificate
active
07423130
ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: 5536637 (1996-07-01), Jacobs
patent: 5639597 (1997-06-01), Lauffer et al.
patent: 6025156 (2000-02-01), Gwynn et al.
patent: 6124433 (2000-09-01), Falb et al.
patent: 6156500 (2000-12-01), Falb
patent: 6162604 (2000-12-01), Jacob
patent: 6228582 (2001-05-01), Rodier et al.
patent: 6395306 (2002-05-01), Cui et al.
patent: 6414117 (2002-07-01), Levinson
patent: 6465185 (2002-10-01), Goldfine et al.
patent: 6498235 (2002-12-01), Sheppard et al.
patent: 6562343 (2003-05-01), Levinson
patent: 6645499 (2003-11-01), Lal et al.
patent: 6730502 (2004-05-01), Van Hijum et al.
patent: 6737522 (2004-05-01), Sundick et al.
patent: WO 97/38085 (1997-10-01), None
patent: WO 9963088 (1999-12-01), None
NCBI Accession No. BE531149, created Aug. 7, 2000, updated Aug. 9, 2000.
NCBI Accession No. AI889075, created Jul. 26, 1999, updated Sep. 1, 1999.
Wells (Sep. 18, 1990) Biochemistry 29(37): 8509-8517.
Ngo et al. (Mar. 2, 1995) “The Protein Folding Problem and Tertiary Structure Prediction, Chapter 14: Computational Complexity Protein Structure Prediction, and the Levinthal Paradox” pp. 492-495.
Bork (2000)Genome Research10:398.
Skolnick and Fetrow (2000)Trends in Biotech. 18(1): 34.
Doerks et al. (Jun. 1998)Trends in Genetics14(6): 248.
Smith and Zhang (Nov. 1997)Nature Biotechnology15:1222.
Brenner (Apr. 1999)Trends in Genetics15(4): 132.
Bork and Bairoch (Oct. 1996)Trends in Genetics12(10): 425.
Valle et al (2003. Expert Rev Mol Diagn. 3(1):55-67).
Hittelman et al, 2001. Ann NY Acad. Sci. 952: 1-12.
Fleischhacker et al, 1995. Modern Pathology. 8(4): 360-365.
Wang et al, 2002 (Oncogene, 21:7598-7604).
Hu et al (2003, Journal of Proteome Research 2:405-412).
Chen et al. (2002, Molecular and Cellular Proteomics 1:304-313).
Lichtinghagen et al. (2002, European Urology. 42: 398-406).
Haynes et al. (1998, Electrophoresis 19:1862-1871).
Gygi et al. (1999, Mol. Cell. Biol. 19:1720-1730).
Lian et al. (2001, Blood 98:513-524).
Fessler et al. (2002, J. Biol. Chem. 277:31291-31302).
Futcher, 1999. Molecular and Cellular Biology. 19(11): 7357-7368.
Nagaraja, 2006, Oncogene. 25: 2328-2338.
Waghray, 2001. Proteomics. 1: 1327-1338.
Sagynaliev, 2005. Proteomics. 5: 3066-3078.
Oda et al, 1997. Virchows Arch. 430: 99-105.
Sugg et al, 1998. Clinical Endocrinology 49: 629-637.
Toler et al, 2003. Am J Obstet Gynecol. 194: e27-e31.
Berner et al, 2003. Histopathol. 42: 546-554.
Brooks et al, 2003. Am J Physiol Renal Physiol. 284: F218-F228.
Klein et al. Selection for Genes Encoding Secreted Proteins and Receptors.Proc. Natl. Acad. Sci., 93:7108-7113 (1996).
Database Search, DNA Sequence Alignments [BLASTN 2.2.1[Jul. 12, 2001], NCBI].
Database Search, Protein Sequence Alignments [BLASTN 2.2.1 [ Jul. 12, 2004], NCBI].
Alberts, et al. 1994.Molecular Biology of the Cell, 3rd Edition, pp. 403-404, 453. New York: Garland Publishing.
Alberts, et al. 2002.Molecular Biology of the Cell 4th Edition, pp. 302, 363-364, 379, 435. New York: Garland Publishing.
Grimaldi, et al. 1989. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene.Blood, 73(8):2081-2085.
Gygi, et al. Mar. 1999. Correlation between Protein and mRNA Abundance in Yeast.Molecular and Cellular Biology, 1720-1730.
Hanna, et al. Aug. 1999. HER-2
eu breast cancer predictive testing.Pathology Associates Medical Laboratories.
Hyman et al. Nov. 2002. Impact of DNA Amplification of Gene Expression Patterns.Cancer Research, 62:6240-6245.
Lewin, B. 1994. Oncogenes: Gene Expression and Cancer, Chap. 39, pp. 1196-1201.Genes V. New York: Oxford University Press.
Lewin, B. 1997. Regulation of Transcription, Chap. 29, pp. 847-848.Genes VI. New York: Oxford University Press.
Meeker, et al. 1990. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia.Blood, 76(2):285-289.
Meric, et al. 2002. Translation initiation in cancer: A novel target for therapy.Molecular Cancer Therapeutics, 1:971-979.
Ørntoft, et al. 2002. Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas.Molecular&Cellular Proteomics, 1:37-45.
Pollack, et al. 2002. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.PNAS, 99(20):12963-12968.
Singleton, et al. 1992. Clinical and pathologic significance of the c-erbB-2 (HER-2
eu) oncogene.Pathol. Annu, 1(27):165-190.
Zhigang, et al. 2004. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer.World Journal of Surgical Oncology, 2:13.
2002-2003 Catalog & Technical Reference, New England BioLabs, Inc., p. 122.
Anderson, et al. 1997. A comparison of selected mRNA and protein abundances in human liver.Electrophoresis, 18:533-537.
Fessler, et al. 2002. A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase.The Journal of Biological Chemistry, 277(35):31291-31302.
Tokunaga, et al. 2000. Application of quantitative RT-PCR using “TaqMan” technology to evaluate the expression of CK 18 mRNA in various cell lines.J. Exp. Clin. Cancer Res., 19(3):375-381.
Abe, et al. “An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue.”Br J Cancer. Dec. 1, 2003; 89(11):2104-9. (Abstract Only).
Alberts, et al. 1994.Molecular Biology of the Cell, 3rd Edition, pp. 1216-1217. New York: Garland Publishing.
Allman, et al. 1996. BCL-6 expression during B-cell activation.Blood, 87(12):5257-5268.
Ando, et al. “Selective apoptosis of natural killer-cell tumors by l-asparaginase.”Br. J. Haematol. Sep. 2005;130(6):860-8. (Abstract Only).
Aust, et al. “Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.”Thyroid. Oct. 1997;7(5):713-24. (Abstract Only).
Barnes, et al. “Expression of embryonic fibronectin isoform EIIIA parallels alpha-smooth muscle actin in maturing and diseased kidney.”J Histochem Cytochem. Jun. 1999;47(6):787-98. (Abstract Only).
Bea, et al. “BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas.”Cancer Res. Mar. 15, 2001;61(6):2409-12. (Abstract Only).
Blaschke, et al. “Rapid quantitation of proinflammatory and chemoattractant cytokine expression in small tissue samples and monocyte-derived dendritic cells: validation of a new real-time RT-PCR technology.”J Immunol Methods. Dec. 1, 2000;246(1-2):79-90. (Abstract Only).
Buckley, et al. “Butyrate-induced reversal of dexamethasone resistance in autonomous rat Nb2 lymphoma cells.” Apoptosis. 1997;2(6):518-28. (Abstract Only).
Caberlotto, et al. “Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression. ”Neurosci Lett. Apr. 23, 1999;265(3):191-4. (Abstract Only).
Caberlotto, et al. “Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain.”Eur J Neurosci. May 2003;17(9):1736-46. (Abstract Only).
Celis, et al. 2000. Gene expression profiling: monitoring transcription and translation products using DNA microarray
Goddard Audrey
Grimaldi J. Christopher
Gurney Austin L.
Watanabe Colin K.
Wood William I.
Barnes Elizabeth M
Genentech Inc.
Howard Zachary C.
Kemmerer Elizabeth C.
Knobbe Martens Olson & Bear LLP
LandOfFree
PRO1158 polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PRO1158 polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PRO1158 polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3980324